Focusing on the Diabetes Patient

Published Online: Friday, November 8, 2013
Follow Pharmacy_Times:
Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, explains why he decided to focus on caring for diabetes patients at his pharmacy. This interview was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.

Related Articles
In patients at risk for type 2 diabetes, diet and exercise have beneficial effects on regulating glucose levels beyond those associated with weight loss.
The FDA refused to approve Novo Nordisk’s ultra-long-acting insulin treatments 2 years ago.
The FDA has approved GlaxoSmithKline’s Tanzeum (albiglutide) subcutaneous injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$